Latest Insider Transactions at Angion Biomedica Corp. (ANGN)
This section provides a real-time view of insider transactions for Angion Biomedica Corp. (ANGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Angion Biomedica Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Angion Biomedica Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2021
|
Itzhak Goldberg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
38,353
-1.82%
|
$613,648
$16.0 P/Share
|
|
Feb 09
2021
|
Gilbert S Omenn Director |
BUY
Conversion of derivative security
|
Indirect |
61,657
+25.87%
|
$678,227
$11.57 P/Share
|
|
Feb 09
2021
|
Karen J Wilson Director |
BUY
Conversion of derivative security
|
Direct |
18,718
+50.0%
|
$205,898
$11.57 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
BUY
Conversion of derivative security
|
Direct |
165,356
+6.05%
|
$1,818,916
$11.57 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
SELL
Open market or private sale
|
Direct |
159,177
-11.64%
|
$2,546,832
$16.0 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
237,152
+14.15%
|
$1,422,912
$6.43 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,966
-2.99%
|
$511,456
$16.0 P/Share
|